NO20032904L - Natriumkanal-modulatorer utledet fra 2-piperidylimidazoler - Google Patents

Natriumkanal-modulatorer utledet fra 2-piperidylimidazoler

Info

Publication number
NO20032904L
NO20032904L NO20032904A NO20032904A NO20032904L NO 20032904 L NO20032904 L NO 20032904L NO 20032904 A NO20032904 A NO 20032904A NO 20032904 A NO20032904 A NO 20032904A NO 20032904 L NO20032904 L NO 20032904L
Authority
NO
Norway
Prior art keywords
piperidylimidazoles
sodium channel
channel modulators
modulators derived
derived
Prior art date
Application number
NO20032904A
Other languages
English (en)
Other versions
NO20032904D0 (no
Inventor
Dennis Bigg
Jacques Pommier
Anne-Marie Liberatore
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20032904L publication Critical patent/NO20032904L/no
Publication of NO20032904D0 publication Critical patent/NO20032904D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20032904A 2000-12-28 2003-06-24 Natriumkanal-modulatorer utledet fra 2-piperidylimidazoler NO20032904D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0017149A FR2818978B1 (fr) 2000-12-28 2000-12-28 Modulateurs de canaux sodiques derives de 2-piperidylimidazoles
PCT/FR2001/004209 WO2002053559A1 (fr) 2000-12-28 2001-12-27 Modulateurs de canaux sodiques derives de 2-piperidylimidazoles

Publications (2)

Publication Number Publication Date
NO20032904L true NO20032904L (no) 2003-06-24
NO20032904D0 NO20032904D0 (no) 2003-06-24

Family

ID=8858291

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032904A NO20032904D0 (no) 2000-12-28 2003-06-24 Natriumkanal-modulatorer utledet fra 2-piperidylimidazoler

Country Status (24)

Country Link
US (1) US20040077640A1 (no)
EP (1) EP1349850B1 (no)
JP (1) JP2004517121A (no)
KR (1) KR100892656B1 (no)
CN (1) CN1214025C (no)
AR (1) AR035613A1 (no)
AT (1) ATE304005T1 (no)
AU (1) AU2002228128B8 (no)
BR (1) BR0116581A (no)
CA (1) CA2432959A1 (no)
CZ (1) CZ20032053A3 (no)
DE (1) DE60113297T2 (no)
DK (1) DK1349850T3 (no)
ES (1) ES2249488T3 (no)
FR (1) FR2818978B1 (no)
HU (1) HUP0600032A2 (no)
IL (1) IL156352A0 (no)
MX (1) MXPA03005914A (no)
NO (1) NO20032904D0 (no)
NZ (1) NZ526394A (no)
PL (1) PL363640A1 (no)
RU (1) RU2275369C2 (no)
WO (1) WO2002053559A1 (no)
ZA (1) ZA200305005B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008001596A (ja) * 2004-09-03 2008-01-10 Astellas Pharma Inc ナトリウムチャネル阻害剤
EP1963280B1 (en) * 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
CN101454299A (zh) 2006-03-27 2009-06-10 东丽株式会社 酰脲衍生物及其医药用途
DE102007047243A1 (de) 2007-09-25 2009-04-02 Karl Storz Gmbh & Co. Kg Bipolares medizinisches Instrument
CN101970432B (zh) * 2008-01-25 2014-05-28 杜邦公司 杀真菌杂环化合物
WO2025122832A1 (en) * 2023-12-07 2025-06-12 Genep Inc. Imidazole compounds and their use as sodium channel inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633882A1 (en) * 1992-04-01 1995-01-18 The University Of Toledo 4- 4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof
US5296609A (en) * 1993-04-09 1994-03-22 Syntex Pharmaceuticals, Ltd. Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives
EP0793653A1 (en) * 1994-11-23 1997-09-10 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
KR19990064117A (ko) * 1995-10-06 1999-07-26 폴락 돈나 엘. 항암 활성과 사이토킨 억제 활성을 갖는 치환된 이미다졸
ES2239357T3 (es) * 1996-06-10 2005-09-16 MERCK & CO., INC. Imidazoles sustituidos que tienen actividad inhibidora de citoquinas.
HUP0302962A2 (hu) * 1998-06-12 2003-12-29 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
TW502019B (en) * 1999-03-26 2002-09-11 Cocensys Inc Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
US6297256B1 (en) * 1999-06-15 2001-10-02 Neurogen Corporation Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
EP1237875B1 (en) * 1999-12-16 2005-08-31 Schering Corporation Substituted imidazole neuropeptide y y5 receptor antagonists

Also Published As

Publication number Publication date
WO2002053559A1 (fr) 2002-07-11
AU2002228128B8 (en) 2007-01-04
KR20030070592A (ko) 2003-08-30
AU2002228128A1 (en) 2002-07-16
FR2818978B1 (fr) 2003-02-28
CN1483029A (zh) 2004-03-17
HK1059784A1 (en) 2004-07-16
CZ20032053A3 (en) 2004-04-14
PL363640A1 (en) 2004-11-29
EP1349850B1 (fr) 2005-09-07
EP1349850A1 (fr) 2003-10-08
FR2818978A1 (fr) 2002-07-05
AU2002228128B2 (en) 2006-08-03
RU2275369C2 (ru) 2006-04-27
CA2432959A1 (fr) 2002-07-11
ES2249488T3 (es) 2006-04-01
ZA200305005B (en) 2004-06-28
ATE304005T1 (de) 2005-09-15
JP2004517121A (ja) 2004-06-10
IL156352A0 (en) 2004-01-04
HUP0600032A2 (en) 2006-06-28
AR035613A1 (es) 2004-06-16
KR100892656B1 (ko) 2009-04-15
NO20032904D0 (no) 2003-06-24
BR0116581A (pt) 2004-01-06
NZ526394A (en) 2004-12-24
DK1349850T3 (da) 2006-01-23
US20040077640A1 (en) 2004-04-22
MXPA03005914A (es) 2003-09-10
CN1214025C (zh) 2005-08-10
RU2003123119A (ru) 2005-01-10
DE60113297D1 (de) 2005-10-13
DE60113297T2 (de) 2006-07-13

Similar Documents

Publication Publication Date Title
DE50107622D1 (de) Wellendichtring
DE60116455D1 (de) Dichtungseinrichtung
ATA6032000A (de) Dichtring-kombination
DE60114391D1 (de) Kanaltrennungsabschirmung
DE60125769D1 (de) Verbessertes elektroentionisierungssystem
DE50105294D1 (de) Dichtungsprofil
FI20001068L (fi) Telekommunikaatiojärjestelmä
DE50108256D1 (de) Dichtungsanordnung
NO20010884D0 (no) Tetningssammenstillinger
DE60118495D1 (de) Doppeldichtung
DE60122247D1 (de) Optischer Multiplexer/Demultiplexer
DE60113246D1 (de) Dichtring
DE50110228D1 (de) Gleitringdichtung
NO20032075D0 (no) Rammer for riggtang
DE10196859T1 (de) Verbesserte Dichtung
IT250181Y1 (it) Custodia perfezionata per rivoltella
DE50110340D1 (de) Splittergefechtskopf zur bekämpfung technischer ziele
DE50010600D1 (de) Dichtungsanordnung
NO20032904D0 (no) Natriumkanal-modulatorer utledet fra 2-piperidylimidazoler
IT1316081B1 (it) Trappola per muridi
DK1134424T3 (da) Tætningshus
EP1501790A4 (en) NEW SODIUM CHANNEL BLOCKERS
DE50107702D1 (de) Zylinderdeckeldichtung
NO20023164L (no) Buekonstruksjon
FI20001603L (fi) Tiivistejõrjestely

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application